Copyright © 2001 by the European Society of Cardiology.
Editorials
Natriuretic peptides to probe haemodynamic overload in hypertrophic cardiomyopathy
Cardiovascular Center, O.L.V. Ziekenhuis, Aalst, Belgium
Abstract
No Abstract
References
- Wei CM, Heublein DM, Perrella MA. Natriuretic peptide system in human heart failure. Circulation. 1993;88:10041009
[Abstract/Free Full Text] - Isnard R, Pousset F, Trochu J. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure. Am J Cardiol. 2000;86:417421[CrossRef][ISI][Medline]
- Briguori C, Betocchi S, Manganelli F. Determinants and clinical significance of natriuretic peptides in hypertrophic cardiomyopathy. Eur Heart J. 2001;22:13281336
[Abstract/Free Full Text] - Criley JM, Siegel RJ. Has obstruction hindered our understanding of hypertrophic cardiomyopathy? Circulation. 1985;72:11481154
[Abstract/Free Full Text] - Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775785
[Free Full Text] - Nishigaki K, Tomita M, Kagawa K. Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1996;28:12341242[Abstract]
- Wijbenga AA, Balk AH, Jonkman FA, Boomsma F, Simoons ML, Man in't Veld AJ. Relation of atrial natriuretic peptide to left ventricular systolic and diastolic function in heart failure. Eur J Heart Fail. 1999;1:5158[CrossRef][ISI][Medline]
- Yamamoto K, Burnett JC, Redfield MM. Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart. Am J Physiol. 1997;273:H2406H2414
- Clarkson PB, Wheeldon NM, MacFadyen RJ, Pringle SD, MacDonald TM. Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure. Circulation. 1996;93:20372042
[Abstract/Free Full Text] - Paulus WJ, Shah AM. NO and cardiac diastolic function. Cardiovasc Res. 1999;43:595606
[Free Full Text] - Colucci WS, Elkayam U, Horton DP. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med. 2000;343:246253
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||